| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 64,414 | 64,372 | 63,924 | 64,212 | | Cost of Revenue | 48,634 | 39,858 | 41,226 | 40,467 | | | Gross Profit | 15,780 | 24,514 | 22,698 | 23,745 | | | Operating Expenses | | Research Development |
-
| (1,902) | 1,902 | 2,061 | | Selling General and Administrative | 16,577 | 22,407 | 16,779 | 14,296 | | Non Recurring | 3 | 51,493 | 3,112 | 1,026 | | Others | 922 | 12,720 | 7,253 | 6,892 | | | | Total Operating Expenses |
-
| 84,718 | 29,046 | 24,275 | | | | Operating Income or Loss | (1,742) | (60,204) | (6,348) | (530) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 111 | (148) | 17 | (59) | | Earnings Before Interest And Taxes | (1,912) | (60,352) | (6,331) | (589) | | Interest Expense |
-
| (164) | 164 | 420 | | Income Before Tax | (1,912) | (60,188) | (6,495) | (1,009) | | Income Tax Expense | 93 | 437 | 45 | (58) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,974) | (60,645) | (6,608) | (910) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,974) | (60,645) | (6,608) | (910) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,974) | ($60,645) | ($6,608) | ($910) |
|
0.02% Nasdaq 
0.04%
Income Statement
